US FDA Tackles HDE 'Probable Benefits' Question In Draft Guidance
Executive Summary
In accordance with the 21st Century Cures Act, FDA has published a draft guidance on how it will assess devices intended for orphan diseases under the humanitarian device exemption pathway. A key part of the guidance attempts to address the agencies thinking on what is considered probable benefit.